The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic Studies

Valproic acid (VPA), its unsaturated metabolites and pent‐4‐enoate (4‐PA) were studied for potential hepatotoxicity in rats. 4‐PA, 4‐en‐VPA and 2,4‐dien‐VPA were potent inducers of microvesicular steatosis in young rats. Microvesicular steatosis induced by the 4‐en‐VPA was accompanied by ultrastructural changes characterized by myeloid bodies, lipid vacuoles and mitochondrial abnormalities. Myeloid bodies and lipid vacuoles were seen to a lesser extent in 2,4‐dien‐VPA and 4‐PA‐treated rats. VPA failed to induce discernible liver lesions in young rats even at near lethal doses of 700 mg per kg per day. The drug did, however, induce hepatic lipid accumulation in mature rats and in young rats dosed concomitantly with phenobarbital. β‐oxidation inhibition and several other biochemical alterations were observed in rats dosed with VPA, its unsaturated metabolites and 4‐PA. It was suggested that β‐oxidation inhibition observed in both VPA and en‐metabolite‐treated rats occurred by different mechanisms. VPA inhibits by a transient sequestering of CoA while the CoA esters of some en‐V,PA‐metabolites, particularly 4‐en‐VPA, inhibit specific enzyme(s) in the β‐oxidation sequences.

[1]  J. McGarry,et al.  Role of carnitine in hepatic ketogenesis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Brendel,et al.  Hypoglycin and hypoglycin-like compounds. , 1969, Pharmacological reviews.

[3]  R. Wannemacher,et al.  Improved radiochemical assay for carnitine and its derivatives in plasma and tissue extracts. , 1978, Clinical chemistry.

[4]  P. Holland,et al.  Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of their coenzyme A esters on enzymes of fatty acid oxidation. , 1973, The Biochemical journal.

[5]  K. Ishak,et al.  Valproate‐Induced Hepatic Injury: Analyses of 23 Fatal Cases , 2007, Hepatology.

[6]  G. Grimber,et al.  Letter to the Editor: A Mechanism for Valproate-Induced Hyperammonemia , 1981, Pediatric Research.

[7]  H. Osmundsen,et al.  A Novel mechanism for inhibition of β‐oxidation by methylenecyclopropylacetyl‐CoA, a metabolite of hypoglycin , 1975, FEBS letters.

[8]  S. Brooks,et al.  Studies on hypoglycin toxicity in rats. I. Changes in hepatic ultrastructure. , 1970, The American journal of pathology.

[9]  N. Gerber,et al.  Reye-like syndrome associated with valproic acid therapy. , 1979, The Journal of pediatrics.

[10]  Chang Lw,et al.  Reye syndrome. Light and electron microscopic studies. , 1973, Archives of pathology.

[11]  J. B. Allred,et al.  Determination of coenzyme A and acetyl CoA in tissue extracts. , 1969, Analytical biochemistry.

[12]  Robert A. Harris,et al.  Influence of valproic acid on hepatic carbohydrate and lipid metabolism. , 1983, Archives of biochemistry and biophysics.

[13]  E. Zafrani,et al.  Sodium Valproate in the Induction of Unusual Hepatotoxicity , 2007, Hepatology.

[14]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[15]  A. Ichinoe,et al.  Sodium valproate-induced liver injury. , 1982, The American journal of gastroenterology.

[16]  H. Osmundsen,et al.  On the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent-4-enoic acid. A way out of the present confusion. , 1976, Biochemical pharmacology.

[17]  H. Zimmerman,et al.  Valproate‐induced hepatic steatogenesis in rats , 1982, Hepatology.

[18]  G. Madge,et al.  Observations on the Pathogenesis of Reye's Syndrome , 1971, Southern medical journal.

[19]  Z. Hruban,et al.  Drug-induced and naturally occurring myeloid bodies. , 1972, Laboratory investigation; a journal of technical methods and pathology.

[20]  H. Sherratt.  Hypoglycin and related hypoglycaemic compounds. , 1969, British medical bulletin.

[21]  N. Sapeika,et al.  Effect of the antiepileptic drug sodium valproate on induction of hepatic microsomal P450. , 1975, Research communications in chemical pathology and pharmacology.

[22]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[23]  H. Gastaut,et al.  A Case of Fatal Toxic Hepatitis: Recommendations for the Administration of Sodium Valproate , 1981, Epilepsia.

[24]  G. Granneman,et al.  The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. II. Intermediary and Valproic Acid Metabolism , 1984, Hepatology.